share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

輝瑞 | 4:持股變動聲明-高管 BOURLA ALBERT
美股sec公告 ·  06/05 05:08
牛牛AI助理已提取核心訊息
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
pfizer inc.(pfe)主席兼首席執行官阿爾伯特·布洛拉於2024年5月31日執行了非衍生證券交易。根據提供的公告,交易的具體細節,包括股份數量、交易價格和總價值,都未公開。該行動反映了布洛拉在公司持股的變化,但沒有額外的信息,無法確定執行後他所持有的總股份數有多少。
pfizer inc.(pfe)主席兼首席執行官阿爾伯特·布洛拉於2024年5月31日執行了非衍生證券交易。根據提供的公告,交易的具體細節,包括股份數量、交易價格和總價值,都未公開。該行動反映了布洛拉在公司持股的變化,但沒有額外的信息,無法確定執行後他所持有的總股份數有多少。

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生,只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。